A blood test that detects carcinoembryonic antigen (CEA) can improve preoperative risk stratification for patients with stage II colon cancer and guide decisions about adjuvant chemotherapy, say ...
ReCAP: Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska Over a 1-year period, the mean ...
“[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and CA19-9) are perfectly situated to ...
Blood-borne biomarkers for early detection of colorectal cancer (CRC) could markedly increase screening uptake. The aim of this study was to evaluate serum carcinoembryonic antigen (CEA), CYFRA21-1 ...
Evaluation of inducible expression of ERCC1 as a biomarker of drug response in human colorectal cancer cell lines. Background: Although in use for almost 30 years, the clinical value of CEA as the ...
A research team led by the Nagoya University Graduate School of Medicine has discovered that the stromal cell-derived factor 4 (SDF-4) protein is a reliable cancer marker. As simple blood tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results